We thus assessed the expression of the early and late T-cell activation markers CD69 and HLA-DR [21], respectively, as well as that of the proliferation marker KI67 according to PD-1 and CD39 expression in memory Tconv from cancer patients. Here, ENTPD1 is linked to cancer.